开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2024-06-19 ms7000001909487480 来自北京

偏重的研究方向：临床
经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2020-08-26 Tina1130

一直卡在awaiting reviewer assignment是怎么回事，求大神指点

174 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2023-11-11 ms4000001197643439 来自上海

2023.11.11进入with editor，希望好运

53 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2024-06-07 ms8097876345829923 来自湖北省

偏重的研究方向：临床
经验分享：6月1日投稿，2天后状态是Under Review

49 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2021-07-26 Davidyang1219

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：流行病学;代谢综合征
经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。

116 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2024-05-13 ms8000002099524009 来自四川省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：超声
经验分享：无

41 0

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2020-07-14 ms8000000089541367

审稿速度:1.0
经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。

200 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2023-03-03 ms3000001690695039 来自广东省

审稿速度:3.0
经验分享：2个月了还在找审稿人

75 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2022-11-19 ms3000000590360295

审稿速度:6.0 | 投稿命中率:50.0
经验分享：b,b,m.,m.

81 0

[GetPortalCommentsPageByObjectIdResponse(id=2210645, encodeId=d65c22106454d, content=偏重的研究方向：临床 经验分享：请问投稿第二天变成under review状态，是在编辑内审，还是送出外审了呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Wed Jun 19 13:22:55 CST 2024, time=2024-06-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=813526, encodeId=0a9c81352633, content=一直卡在awaiting reviewer assignment是怎么回事，求大神指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Wed Aug 26 20:11:50 CST 2020, time=2020-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2167964, encodeId=fd01216e964f1, content=2023.11.11进入with editor，希望好运, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b126400305, createdName=ms4000001197643439, createdTime=Sat Nov 11 10:13:07 CST 2023, time=2023-11-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208845, encodeId=19b72208845a9, content=偏重的研究方向：临床 经验分享：6月1日投稿，2天后状态是Under Review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12c51747436, createdName=ms8097876345829923, createdTime=Fri Jun 07 19:03:28 CST 2024, time=2024-06-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1002707, encodeId=0e2a1002e0768, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：流行病学;代谢综合征 经验分享：一审不到一个月，审稿速度5星，意见也比较友好；总耗时大概1.5月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=19961945238, createdName=Davidyang1219, createdTime=Mon Jul 26 11:47:47 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2204534, encodeId=15592204534c5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：超声 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb0c8286816, createdName=ms8000002099524009, createdTime=Mon May 13 21:02:01 CST 2024, time=2024-05-13, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=802713, encodeId=9cd9802e13f8, content=审稿速度:1.0 经验分享：我今年4月初投稿，5月份给了一审结果，一次大修，一次小修后接受。编辑很严谨，很注意细节，给的修改意见也很中肯，平均审稿时间为一个月，三个月后接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84ad5397981, createdName=ms8000000089541367, createdTime=Tue Jul 14 01:32:39 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2117377, encodeId=9100211e377d8, content=审稿速度:3.0 经验分享：2个月了还在找审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aeb8481493, createdName=ms3000001690695039, createdTime=Fri Mar 03 15:46:45 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2101562, encodeId=ce2e21015629f, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：b,b,m.,m., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=614a8379235, createdName=ms3000000590360295, createdTime=Sat Nov 19 22:08:04 CST 2022, time=2022-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552803, encodeId=0f8e55280326, content=刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=349, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/11/35371cded71b6a8a68436bbf6ac23d30.jpg, createdBy=ae9e1667629, createdName=chazwf, createdTime=Wed Feb 21 16:30:00 CST 2018, time=2018-02-21, status=1, ipAttribution=)]

2018-02-21 chazwf

刚投稿完成，状态就变成了Under Review，有没有小伙伴碰到过这样的？这个杂志没有with edior等这样的状态吗？

349 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务